Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119846292 | 11984629 | 2 | F | 201512 | 20160120 | 20160201 | 20160712 | PER | US-ASTRAZENECA-2013SE56179 | ASTRAZENECA | 880.00 | MON | F | Y | 72.60000 | KG | 20160712 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119846292 | 11984629 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | 250 MCG / 2.4 ML PEN | U | U | 21773 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | |||||||
| 119846292 | 11984629 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | U | U | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||
| 119846292 | 11984629 | 3 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | U | U | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||
| 119846292 | 11984629 | 4 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | U | U | AZ150031 | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QD | ||||
| 119846292 | 11984629 | 5 | SS | LISINOPRIL HCTZ | HYDROCHLOROTHIAZIDELISINOPRIL | 1 | Oral | 20/25 MG, EVERY DAY | U | 0 | TABLET | ||||||||
| 119846292 | 11984629 | 6 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | U | 0 | TABLET | |||||||||
| 119846292 | 11984629 | 7 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | U | 0 | 850 | MG | BID | |||||||
| 119846292 | 11984629 | 8 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | U | 0 | 500 | MG | BID | |||||||
| 119846292 | 11984629 | 9 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | 140 MG, BID | 0 | 140 | MG | BID | ||||||||
| 119846292 | 11984629 | 10 | C | CLONIDINE. | CLONIDINE | 1 | .1 MG, TID | 0 | .1 | MG | TID | ||||||||
| 119846292 | 11984629 | 11 | C | CARVEDILOL. | CARVEDILOL | 1 | 0 | 12.5 | MG | BID | |||||||||
| 119846292 | 11984629 | 12 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | .05 | MG | QD | |||||||||
| 119846292 | 11984629 | 13 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | 25 | MG | QD | |||||||||
| 119846292 | 11984629 | 14 | C | CLOPIDOGREL BISULFATE. | CLOPIDOGREL BISULFATE | 1 | 0 | 75 | MG | QD | |||||||||
| 119846292 | 11984629 | 15 | C | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | 0 | 40 | MG | TABLET | QD | ||||||||
| 119846292 | 11984629 | 16 | C | PANTOPRAZOLE SODIUM. | PANTOPRAZOLE SODIUM | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 119846292 | 11984629 | 17 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 0 | 50 | MG | QD | |||||||||
| 119846292 | 11984629 | 18 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | 0 | 12.5 | MG | BID | |||||||||
| 119846292 | 11984629 | 19 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | 0 | 50 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119846292 | 11984629 | 1 | Type 2 diabetes mellitus |
| 119846292 | 11984629 | 2 | Type 2 diabetes mellitus |
| 119846292 | 11984629 | 3 | Type 2 diabetes mellitus |
| 119846292 | 11984629 | 4 | Type 2 diabetes mellitus |
| 119846292 | 11984629 | 5 | Hypertension |
| 119846292 | 11984629 | 7 | Type 2 diabetes mellitus |
| 119846292 | 11984629 | 8 | Type 2 diabetes mellitus |
| 119846292 | 11984629 | 11 | Hypertension |
| 119846292 | 11984629 | 12 | Thyroid disorder |
| 119846292 | 11984629 | 13 | Thyroid disorder |
| 119846292 | 11984629 | 14 | Cardiac disorder |
| 119846292 | 11984629 | 15 | Blood cholesterol increased |
| 119846292 | 11984629 | 16 | Gastrooesophageal reflux disease |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119846292 | 11984629 | Blood glucose increased | |
| 119846292 | 11984629 | Dizziness | |
| 119846292 | 11984629 | Drug dose omission | |
| 119846292 | 11984629 | Intentional product misuse |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119846292 | 11984629 | 1 | 201306 | 0 | ||
| 119846292 | 11984629 | 2 | 20130710 | 0 | ||
| 119846292 | 11984629 | 3 | 2013 | 0 |